|
[1]
|
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395(10225):709 − 33. https://doi.org/10.1016/S0140-6736(20)30045-3CrossRef
|
|
[2]
|
Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen XY, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2020;75(S1):A6 − 7. https://doi.org/10.1053/j.ajkd.2019.09.003CrossRef
|
|
[3]
|
Ma LY, Wang ZW, Fan J, Hu SS. Epidemiology and management of hypertension in China: an analysis using data from the Annual report on cardiovascular health and diseases in China (2021). Chin Gene Pract 2022;25(30):3715-20. https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0502. (In Chinese |
|
[4]
|
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1223 − 49. https://doi.org/10.1016/S0140-6736(20)30752-2CrossRef
|
|
[5]
|
Wang LM, Xu X, Zhang M, Hu CH, Zhang X, Li C, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med 2023;183(4):298 − 310. https://doi.org/10.1001/jamainternmed.2022.6817CrossRef
|
|
[6]
|
Zhang M, Wu J, Zhang X, Hu CH, Zhao ZP, Li C, et al. Prevalence and control of hypertension in adults in China, 2018. Chin J Epidemiol 2021;42(10):1780 − 9. https://doi.org/10.3760/cma.j.cn112338-20210508-00379CrossRef
|
|
[7]
|
Zhou MG, Wang HD, Zeng XY, Yin P, Zhu J, Chen WQ, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019;394(10204):1145 − 58. https://doi.org/10.1016/S0140-6736(19)30427-1CrossRef
|
|
[8]
|
Zhang N, Sun XJ, Li C, Wang X, Liu K. Analyzing the equity of health resources allocation in China based on Theil Index. Chin Health Serv Manage 2014;31(2):88-91. https://d.wanfangdata.com.cn/periodical/zgwssygl201402003. (In Chinese). |
|
[9]
|
Chinese Society of Nephrology. Guidelines for hypertension management in patients with chronic kidney disease in China (2023). Chin J Nephrol 2023;39(1):48-80. http://qikan.cqvip.com/Qikan/Article/Detail?id=7109247324. (In Chinese). |
|
[10]
|
Ren Y, Wang ZW, Wang QJ. The trend of hypertension-related chronic kidney disease from 1990 to 2019 and its predictions over 25 years: an analysis of the Global Burden of Disease Study 2019. Int Urol Nephrol 2023;56(2):707 − 18. https://doi.org/10.1007/s11255-023-03707-wCrossRef
|